| Literature DB >> 35382846 |
Jeffrey B MacLeod1, Kenneth D'Souza1, Christie Aguiar1, Craig D Brown2, Zlatko Pozeg2, Christopher White2, Rakesh C Arora3, Jean-François Légaré2, Ansar Hassan4.
Abstract
BACKGROUND: While fast track clinical pathways have been demonstrated to reduce resource utilization in patients undergoing cardiac surgery, it remains unclear as to whether they adversely affect post-operative outcomes. The purpose of this study was to determine the impact of fast tracking on post-operative outcomes following cardiac surgery.Entities:
Keywords: Outcomes; Patient safety; Postoperative care
Mesh:
Year: 2022 PMID: 35382846 PMCID: PMC8983083 DOI: 10.1186/s13019-022-01815-9
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Inclusion/exclusion criteria
Baseline characteristics
| Characteristics, n (%) | Fast track (n = 245) | Control (n = 3007) | p value |
|---|---|---|---|
| Age, years, mean ± SD | 63 ± 8 | 63 ± 8 | 0.27 |
| Age ≥ 70 years | 58 (23.7) | 724 (24.1) | 0.95 |
| Female sex | 41 (16.7) | 558 (18.6) | 0.53 |
| Smoking history | 165 (67.3) | 1996 (66.4) | 0.81 |
| Hypertension | 174 (71.0) | 2141 (71.2) | 1.00 |
| Dyslipidemia | 189 (77.1) | 2340 (77.8) | 0.87 |
| Diabetes | 88 (35.9) | 1076 (35.8) | 1.00 |
| CVD | 15 (6.1) | 318 (10.6) | 0.04 |
| PVD | 19 (7.8) | 340 (11.3) | 0.11 |
| Recent MI ≤ 21 days | 84 (34.3) | 946 (31.5) | 0.40 |
| Renal failure | 2 (0.8) | 79 (2.6) | 0.12 |
| Unstable angina | 137 (55.9) | 1426 (47.4) | 0.01 |
| Atrial fibrillation | 12 (4.9) | 210 (7.0) | 0.27 |
| COPD | 11 (4.5) | 297 (9.9) | 0.008 |
| NYHA class 4 | 167 (68.2) | 1706 (56.7) | 0.0006 |
| EF < 40% | 10 (4.1) | 303 (10.1) | 0.003 |
| Urgent status | 161 (65.7) | 1631 (54.2) | 0.0007 |
COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; EF, ejection fraction; MI, myocardial infraction; NYHA, New York Heart Association; PVD, peripheral vascular disease
Intraoperative characteristics
| Characteristics, n (%) | Fast track (n = 245) | Control (n = 3007) | p value |
|---|---|---|---|
| CABG | 220 (89.8) | 2375 (79.0) | < 0.0001 |
| Valve | 21 (8.6) | 364 (12.1) | |
| CABG + valve | 4 (1.6) | 268 (8.9) | |
| CPB time, mdn (IQR) | 79 (64–95) | 92 (74–113) | < 0.0001 |
| XC time, mdn (IQR) | 60 (46–73) | 69 (52–88) | < 0.0001 |
| Inotropes | 29 (11.8) | 546 (18.2) | 0.02 |
CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; XC- cross clamp
In-hospital outcomes
| Characteristics, n (%) | Fast track (n = 245) | Control (n = 3007) | p value |
|---|---|---|---|
| Mortality | 0 (0.0) | 23 (0.8) | 0.41 |
| Reop for bleeding | 0 (0.0) | 17 (0.6) | 0.63 |
| Wound infection | 13 (5.3) | 88 (2.9) | 0.06 |
| UTI | 1 (0.4) | 23 (0.8) | 1.00 |
| Sepsis | 0 (0.0) | 9 (0.3) | 1.00 |
| Atrial fibrillation | 70 (28.6) | 1119 (37.2) | 0.008 |
| Renal failure | 6 (2.4) | 152 (5.1) | 0.09 |
| CVA | 1 (0.4) | 17 (0.6) | 1.00 |
| TIA | 0 (0.0) | 11 (0.4) | 1.00 |
| Initial vent time, h | 4.3 (3.3–5.2) | 5.6 (4.4–7.7) | < 0.0001 |
| Reintubation | 0 (0.0) | 5 (0.2) | 1.00 |
| BiPAP | 0 (0.0) | 1 (0.0) | 1.00 |
| Initial ICU time, h | 7.8 (6.5–9.4) | 20.4 (17.3–22.1) | < 0.0001 |
| Prolonged ventilation > 24 h | 0 (0.0) | 8 (0.3) | 1.00 |
| Readmission to ICU | 0 (0.0) | 40 (1.3) | 0.07 |
| Postop LOS, days, median (IQR) | 5 (4–6) | 5 (4–6) | 0.0001 |
| Postop LOS > 5 days | 72 (29.4) | 1205 (40.1) | 0.001 |
| Expired | 0 (0.0) | 23 (0.8) | 0.0007 |
| Home | 212 (86.5) | 2344 (78.6) | |
| Home EMH | 12 (4.9) | 279 (9.3) | |
| Other service | 2 (0.8) | 12 (0.4) | |
| Other institution | 19 (7.8) | 349 (11.7) |
BiPAP, bilevel Positive Airway Pressure; CVA, cerebrovascular accident; EMH, extramural home care; TIA, transient ischemic attack; UTI, urinary tract infection
30-day postoperative outcomes
| Characteristics, n (%) | Fast track | Control | p value |
|---|---|---|---|
| Compositea | 104 (42.4) | 1549 (51.5) | 0.008 |
| Mortality | 0 (0.0) | 26 (0.9) | 0.26 |
| Wound infection | 29 (11.8) | 353 (11.7) | 1.000 |
| UTI | 4 (1.6) | 36 (1.2) | 0.54 |
| Sepsis | 0 (0.0) | 9 (0.3) | 1.00 |
| Atrial fibrillation | 70 (28.6) | 1170 (38.9) | 0.002 |
| Renal failure | 6 (2.4) | 156 (5.2) | 0.08 |
| CVA | 3 (1.2) | 32 (1.1) | 0.74 |
| TIA | 1 (0.4) | 21 (0.7) | 1.00 |
| Readmission | 13 (5.3) | 308 (10.2) | 0.02 |
aMortality, wound infection, UTI, sepsis, atrial fibrillation, renal failure, CVA, TIA, readmission
Logistic regression (30-day composite)
| Variable | OR | 95% CI | p value | |
|---|---|---|---|---|
| 2.5 | 97.5 | |||
| Fast track | 0.75 | 0.57 | 0.98 | 0.03 |
| Age, years | 1.05 | 1.04 | 1.06 | < 0.0001 |
| Hypertension | 1.26 | 1.07 | 1.48 | 0.005 |
| CVD/PVD | 1.33 | 1.10 | 1.60 | 0.004 |
| COPD | 1.31 | 1.02 | 1.68 | 0.03 |
| NYHA class 4 | 1.25 | 1.08 | 1.45 | 0.003 |
| CABG | 1.00 | - | - | - |
| Valve | 1.74 | 1.38 | 2.20 | < 0.0001 |
| CABG + valve | 1.65 | 1.26 | 2.16 | 0.0003 |
Other variables considered: female sex, smoking history, dyslipidemia, diabetes, MI < = 21 days, renal failure, EF < 40%, urgent status, inotropes after OR. C = 0.64
30-day postoperative outcomes, matched
| Characteristics, n (%) | Fast track | Control | p value |
|---|---|---|---|
| Compositea | 104 (42.4) | 109 (44.5) | 0.72 |
| Mortality | 0 (0.0) | 1 (0.4) | 1.00 |
| Wound infection | 29 (11.8) | 26 (10.6) | 0.77 |
| UTI | 4 (1.6) | 5 (2.0) | 1.00 |
| Sepsis | 0 (0.0) | 0 (0.0) | 1.00 |
| Atrial fibrillation | 70 (28.6) | 82 (33.5) | 0.28 |
| Renal failure | 6 (2.4) | 5 (2.0) | 1.00 |
| CVA | 3 (1.2) | 2 (0.8) | 1.00 |
| TIA | 1 (0.4) | 0 (0.0) | 1.00 |
| Readmission | 13 (5.3) | 22 (9.0) | 0.16 |
aMortality, wound infection, UTI, sepsis, atrial fibrillation, renal failure, CVA, TIA, readmission